SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001140361-24-005311
Filing Date
2024-02-02
Accepted
2024-02-02 16:05:54
Documents
1
Effectiveness Date
2024-02-02

Document Format Files

Seq Description Document Type Size
1 15-12G ef20020142_1512g.htm 15-12G 11213
  Complete submission text file 0001140361-24-005311.txt   12227
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-35921 | Film No.: 24591376
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)